 |
인쇄하기
취소
|
Test scandals dragged down pharmaceutical stock prices
Ovrall pharmaceutical industry stocks have been classified as a stable item and therefore assessed with high valuation so far but the recent bio equivalency test scandal has dragged its prices down in the Korea Stock Exchange markets.
The Kosdaq market showed on May 18 that out of the total 75 companies only 4 companies including Shinil, Kkeunwha, Daehan Newpharm and InBionet slightly rose b...
The Kosdaq market showed on May 18 that out of the total 75 companies only 4 companies including Shinil, Kkeunwha, Daehan Newpharm and InBionet slightly rose b...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.